SCHEMBL9975233

SCHEMBL9975233

Nc1nc(-c2ccccc2)cn2c(-c3ccc(C(=O)NC4CC4)cc3)cnc12

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15143931 0.86 TTK (0.71) TTK
SCHEMBL2371344 0.85 TTK (1.00) TTK
SCHEMBL9975212 0.85 TTK (0.78) TTK
SCHEMBL2370850 0.85 TTK (1.00) TTK
SCHEMBL9936302 0.84 TTK (0.77) TTK
SCHEMBL9936657 0.84 TTK (0.82) TTK
SCHEMBL2371412 0.84 TTK (0.74) TTK
SCHEMBL9936168 0.84 TTK (0.79) TTK
SCHEMBL2372438 0.84 TTK (0.84) TTK
SCHEMBL9975199 0.84 TTK (0.76) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012080230-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO disclosed